Wednesday, 26 November 2025 – “Atraktos” Venue
FairLife Lung Cancer Care holds its 5th annual conference titled “Lung Cancer – From Prevention to Holistic Care – Bridging Science and Society – Centering on Life“ on 26 November 2025, 09:30 to 20:00 at the Atraktos venue (Marathonomachon 8, Athens) and will also be broadcast online on the organization’s channels. The conference is the flagship event of FairLife L.C.C.’s November activities for Lung Cancer Awareness Month.
Please register to attend:
For details on the conference agenda, please visit: https://fairlifelcc.com/en/conferences/lung-cancer-from-prevention-to-holistic-care/agenda/
The 5th hybrid Conference of FairLife L.C.C. continues the organization’s long-standing tradition of promoting information and awareness about lung cancer. This year’s conference focuses on the journey from prevention to holistic care, integrating scientific knowledge, clinical expertise, and patients’ needs.
Insights into challenges
The aim of the conference is to provide insight into current challenges, as well as to present solutions and recommendations across key areas, including prevention and early detection, screening, research and innovation, diagnostic tools and dilemmas, early-stage and metastatic lung cancer, small-cell lung cancer, and the continuum from diagnosis to care.
The 5th FairLife L.C.C. Conference is addressed to individuals affected by lung cancer, their families and caregivers, healthcare professionals, scientific organizations, medical students, policymakers, stakeholders, and the wide public.
The conference will be moderated by journalist Elena Papadimitriou.
Simultaneous interpretation will be provided (Greek-English).
Latest advances in lung cancer detection and care
Over 60 speakers and commentators will take part in the conference, representing organizations from the scientific, academic, and research communities both in Greece and internationally. The event will also host representatives of the Church of Greece and the Hellenic State, alongside patient organizations and pharmaceutical industry leaders.
Participants will present the latest advances in lung cancer prevention and early diagnosis, highlighting the critical role of screening programs and public awareness. The economic, scientific, and societal aspects of implementing prevention strategies will be explored, and the outcomes of research initiatives and innovative projects will be shared.
Discussions will also cover the use of artificial intelligence and digital tools in diagnosis, as well as the opportunities for clinical trials and translational research in Greece. Special attention will be given to interdisciplinary collaboration for optimizing patient care, therapeutic approaches for early and metastatic lung cancer, and holistic patient support, including prevention, nutrition, exercise, and psychosocial empowerment.
Distinguished speakers
Opening Addresses by: Korina Pateli Bell, President of FairLife L.C.C., Representative of His Beatitude Ieronymos II, Archbishop of Athens and All Greece, Adonis Georgiadis* – Minister of Health, Irini Agapidaki, Deputy Minister of Health*, Marios Themistocleous – Deputy Minister of Health, Ioannis Gravaris, Former Vice President of the Council of State, Jesme Fox, Medical Director, Roy Castle Lung Cancer Foundation, UK and Secretary, Global Lung Cancer Coalition, Debra Montague, President of Lung Cancer Europe (LuCE).
The conference’s introductory session will host Konstantinos N. Syrigos, MD, PhD, FCCP, Professor & Director, School of Medicine, National and Kapodistrian University of Athens, President of the Hellenic Society for Lung Cancer (HeALC), who will discuss lung cancer as a major public health challenge.
Korina Pateli Bell, President of FairLife L.C.C., highlighted the significance of the conference, stating:
“With great pride and deep emotion, we welcome you to the 5th FairLife Conference, a true milestone in our ongoing journey toward the prevention and holistic care of lung cancer. Five years of dedication, collaboration, and action have brought us here, united by a shared mission: to make early diagnosis accessible to all, to alleviate suffering, and to inspire hope. This year not only continues our efforts but also reinforces our commitment to move forward even more dynamically — powered by science, guided by the voices of patients, and strengthened by societal unity — toward a future where prevention becomes a way of life.”
Auspices, sponsors and support
The conference is held under the auspices of: Holy Archdiocese of Athens and All Greece, Hellenic Society of Medical Oncology (HeSMO), Hellenic Thoracic Society (HTS), Hellenic Society of Radiation Oncology (HESRO), Hellenic Radiological Society (HELRAD), Hellenic Association of Lung Cancer (HeALC), Hellenic Society of Pathology, Hellenic Society of Thoracic and Cardiovascular Surgeons, Hellenic Nurses Association, Women for Oncology (W4O-Hellas), Hellenic Federation of Cancer (ELLOK), Greek Patients’ Association, Hellenic Foundation for Cancer Research (HFCR), International Association for the Study of Lung Cancer (IASLC), Global Lung Cancer Coalition (GLCC), Lung Cancer Europe (LuCE), Hellenic Association of Pharmaceutical Companies (SFEE), PhARMA Innovation Forum (PIF).
Kindly supported by:
Distinguished Sponsor: MSD
Major Sponsors: AstraZeneca, GSK
Sponsors: Roche, Daiichi Sankyo Greece, Johnson & Johnson, Genesis Pharma, PharmaServe Lilly
Supporters: Affidea, AMGEN, VIANEX, BMS, ISTODIEREVNITIKI, KARYO, Agios Loukas, Genotypos
Communication Sponsors: ETS Events and Travel Solutions & Live MeD, ΑCS, CATALYTICA, INNEWS, REPUTATION UNIQUE, WASP Studio
